Improving breast cancer multidisciplinary meetings through streamlining with protocol-based management.

IF 4.1 Q1 HEALTH CARE SCIENCES & SERVICES BMJ Health & Care Informatics Pub Date : 2024-09-24 DOI:10.1136/bmjhci-2023-100949

Aaditya Prakash Sinha, Katie Badawy, Belul Shifa, Zhane Peterson, Mohamed Attia, Sarah Pinder, Arnie Purushotham

{"title":"Improving breast cancer multidisciplinary meetings through streamlining with protocol-based management.","authors":"Aaditya Prakash Sinha, Katie Badawy, Belul Shifa, Zhane Peterson, Mohamed Attia, Sarah Pinder, Arnie Purushotham","doi":"10.1136/bmjhci-2023-100949","DOIUrl":null,"url":null,"abstract":"Objectives: Multidisciplinary meetings (MDMs) are part of standard of care for patients with cancer. Streamlining is essential for high-quality care and efficiency. This study evaluated the feasibility of implementing a protocol to remove patients with benign breast disease from discussion at the MDM.Methods: A prospective review of 218 MDMs evaluated patients with benign breast disease over 22 months. This was followed by a protocol implementation phase over 54 MDMs (6.5 months). Patients meeting specific criteria were excluded from discussion.Results: On average, each MDM consisted of 37 patients, 34.2% of whose conditions were benign and potentially could have been removed from discussion. The implementation phase showed 708/2248 patients (32.5%) were benign of which 631 cases (89%) met the eligibility criteria and were removed from the MDM list allowing more time for discussion of complex cases.Conclusion: Implementing a protocol can safely exclude patients with benign disease from MDM discussion.","PeriodicalId":9050,"journal":{"name":"BMJ Health & Care Informatics","volume":null,"pages":null},"PeriodicalIF":4.1000,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Health & Care Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjhci-2023-100949","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: Multidisciplinary meetings (MDMs) are part of standard of care for patients with cancer. Streamlining is essential for high-quality care and efficiency. This study evaluated the feasibility of implementing a protocol to remove patients with benign breast disease from discussion at the MDM.

Methods: A prospective review of 218 MDMs evaluated patients with benign breast disease over 22 months. This was followed by a protocol implementation phase over 54 MDMs (6.5 months). Patients meeting specific criteria were excluded from discussion.

Results: On average, each MDM consisted of 37 patients, 34.2% of whose conditions were benign and potentially could have been removed from discussion. The implementation phase showed 708/2248 patients (32.5%) were benign of which 631 cases (89%) met the eligibility criteria and were removed from the MDM list allowing more time for discussion of complex cases.

Conclusion: Implementing a protocol can safely exclude patients with benign disease from MDM discussion.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

通过基于协议的管理简化乳腺癌多学科会议。

目的：多学科会议（MDM）是癌症患者标准护理的一部分。精简会议对于提高医疗质量和效率至关重要。本研究评估了在多学科会议讨论中剔除良性乳腺疾病患者的方案的可行性：方法：在 22 个月内对 218 名乳腺良性疾病患者进行了前瞻性审查。随后在 54 次 MDM（6.5 个月）中进行了协议实施阶段。符合特定标准的患者被排除在讨论之外：平均而言，每个 MDM 包括 37 名患者，其中 34.2% 的病情为良性，有可能被排除在讨论之外。实施阶段的结果显示，708/2248 例患者（32.5%）为良性，其中 631 例（89%）符合资格标准，被从 MDM 名单中剔除，从而有更多时间讨论复杂病例：结论：实施协议可以安全地将良性疾病患者排除在 MDM 讨论之外。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊